Precisely controlled progenitor proliferation is essential for normal development. However, molecular mechanisms, which control the correct timing of cell cycle withdrawal during development, have been poorly understood. We show here that ubc9, a sumo-conjugating enzyme, controls the cell cycle exit of retinal progenitors. We found that ubc9 is highly expressed in retinal progenitors and stem cells in Xenopus embryos. Ubc9 physically and functionally associates with Xenopus hmgb3, which is required for retinal cell proliferation, and prolonged expression of ubc9 and hmgb3 results in suppression of the cell cycle exit of retinal progenitors in a sumoylation-dependent manner. Overexpression of ubc9 and hmgb3 decreased expression of the cell-cycle inhibitor p27
Introduction
The vertebrate neural retina is a complex sensory tissue whose function depends on the production of a sufficient number of cells of each retinal cell type and the correct formation of laminar cytoarchitecture. The seven major cell types that compose the neural retina arise from a pool of multipotent progenitors (Young, 1985; Cepko et al., 1996) . Birthdating studies have demonstrated that the seven retinal cell types are generated in an evolutionarily conserved order during development, although multiple cell types are simultaneously produced at any given developmental stage (Cayouette et al., 2006; Cepko et al., 1996) . Therefore, retinal progenitor cells stop proliferation to differentiate into the cell types that are generated earlier, but also proliferate extensively at an appropriate rate to produce a sufficient number of later cell types. Thus, cell proliferation and cell differentiation occur in parallel in the developing vertebrate retina (Cepko et al., 1996; Donovan and Dyer, 2005; Harris, 2009; Levine and Green, 2004; Young, 1985) . A number of extrinsic cues, including Wnt, Hedgehog and Notch signaling pathways have been implicated in the control of retinal progenitor proliferation and differentiation in the developing retina (Denayer et al., 2008; Dorsky et al., 1997; Van Raay et al., 2005; Wallace, 2008) . On the other hand, the significance of the cell-intrinsic program has been suggested by the clonal density culture of retinal progenitor cells from the rat retina at embryonic day 17.5 (E17.5) (Cayouette et al., 2003) . A number of homeodomain transcription factors have been implicated in the control of retinal progenitor proliferation, including rax/Rx, Pax6, Chx10, Six3, six6/optx2 and Prox1. They are involved in the regulation of cell fate competency, cell proliferation and cell differentiation of retinal progenitors (Burmeister et al., 1996; Casarosa et al., 2003; Dyer et al., 2003; Furukawa et al., 2000; Green et al., 2003; Li et al., 2002; Marquardt et al., 2001; Zuber et al., 1999) . However, molecular mechanisms controlling the balance of two opposing cell behaviors, cell proliferation and cell cycle exit during development, remain to be elucidated.
Cyclin-dependent kinase inhibitors (CKI) play a significant role in the regulation of the cell cycle. Two families of Cdk inhibitors, the Cip/Kip family, which includes p27 Kip1 , p21 Cip1 and p57 Kip2 , and the Ink4 family, comprised of p16 Ink4a , p15
Ink4b
, p18 Ink4c and p19
Ink4d
, have been identified. CKI can inhibit the various cyclin-Cdk complexes that control G1 progression and entry into the S phase, and its overexpression in various cell lines arrests the cell cycle in G1 (Besson et al., 2008; Sherr and Roberts, 1999) . In mice p27
Kip1 regulates the cell cycle withdrawal of late retinal progenitor cells, and in Xenopus p27 Xic1 regulates cell cycle exit and Müller glia development in the developing retina (Levine et al., 2000; Ohnuma et al., 1999) . Sumoylation is a highly conserved evolutionary pathway, from yeast to vertebrates. Ubc9 is the only known small ubiquitin-related modifier (sumo) E2-conjugating enzyme. In Saccharomyces cerevisiae, ubc9 depletion results in cell cycle arrest at the G2/M phase (Seufert et al., 1995) . By contrast, in Schizosaccharomyces pombe, the hus5 Developmental Biology 347 (2010) [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] (ubc9 homolog) deletion mutant is viable, however, the cells exhibit high levels of abortive mitosis and chromosome missegregation (alKhodairy et al., 1995) . RNAi-mediated knockdown of ubc9 in Caenorhabditis elegans results in embryonic arrest after gastrulation and pleiotropic defects in larval development such as vulval eversion at the fourth larval stage and abnormal tail morphology (Jones et al., 2002) . In Drosophila melanogaster, the ubc9 lethal mutant, known as lesswright, dominantly suppresses the nondisjunction and cytological defects of female meiotic mutations that affect spindle formation (Apionishev et al., 2001) . In zebrafish, ubc9 regulates mitosis and cell survival during development. Loss of ubc9 leads to compromised mitosis and cellular overgrowth, and ubc9 is required for tissuespecific cell viability in zebrafish (Nowak and Hammerschmidt, 2006) . In mice, the ubc9-mediated sumo pathway is essential for nuclear integrity and chromosome segregation (Nacerddine et al., 2005) . Sumo post-translationally modifies many proteins with roles in diverse processes including regulation of transcription, chromatin structure, DNA repair, protein localization, and protein activity (Geiss-Friedlander and Melchior, 2007; Hay, 2005; Johnson, 2004) . It was reported that neural crest precursor formation is regulated by sumoylation of SoxE in Xenopus, resulting in a change in the physiological role of the SoxE protein (Taylor and Labonne, 2005) . Recently, it was also reported that sumoylation has an important role in retinal photoreceptor differentiation (Onishi et al., 2009 ). However, the exact role of ubc9 in retinal development remains to be elucidated.
Rax/Rx is a transcription factor that is predominantly expressed in retinal progenitors and is essential for eye development in vertebrates (Furukawa et al., 1997; Mathers et al., 1997) . Rax is conserved among species, including human, mouse, chicken, fish and Xenopus. We previously demonstrated that Xenopus high mobility group box 3 (hmgb3) is one of the downstream factors of rax (Terada et al., 2006) . Overexpression and loss-of-function experiments have indicated that hmgb3 has a significant role in retinal progenitor proliferation during eye development in Xenopus. Hmgb3 is an evolutionally conserved nuclear protein without a transactivation domain and has been thought to function as a chromatin modulator, suggesting that hmgb3 functions through a protein complex. In the current study, we identified ubc9, a sumo conjugating enzyme, to be an interacting partner of hmgb3. We demonstrated that ubc9 regulates retinal progenitor proliferation in a hmgb3-dependent manner, at least in part, via the suppression of p27
Xic1 expression through Sp1 sumoylation. Our results suggest that protein sumoylation plays an important role in controlling retinal progenitor proliferation.
Materials and methods

Yeast two-hybrid assays
We carried out a yeast two-hybrid screen using MATCHMAKER GAL4 Two-Hybrid System 3 (Clontech). The AH109 yeast strain bearing the bait plasmid pGBKT7-hmgb3 was transformed with the mouse retinal (Postnatal day 0 (P0)-P3) cDNA library in a pGADT7 vector. Initially, about 400,000 clones were screened. Yeast colonies that grew at 30°C on SD-Trp-Leu-His were re-streaked on SD-TrpLeu-His-Ade (218 colonies). Streaked yeast colonies that grew on SDTrp-Leu-His-Ade (121 colonies) were subjected to the β-galactosidase (β-gal) assay. 24 colonies were positive in the β-gal assay. Rescued plasmids from yeast into Escherichia coli strain DH5α were classified by enzyme digestion pattern. Each representative plasmid was reintroduced into the yeast strain AH109 together with pGBKT7-hmgb3 to confirm the reproducibility and specificity of interactions. Seven clones were obtained and six of them were ubc9 cDNAs. The amino acid sequences of mouse ubc9 and Xenopus ubc9 are identical. Therefore, the mouse ubc9 cDNA was used for overexpression experiments using Xenopus embryos.
Embryo manipulations
Embryos were obtained from Xenopus laevis adult frog by hormoneinduced egg laying and in vitro fertilization. Embryos were staged according to Nieuwkoop and Faber (1994) . Glucocorticoid receptor fusion proteins were activated by adding 25 μM dexamethasone (DEX) (Sigma, D1756) into the culture medium. Injected embryos were raised at 15°C. Xenopus embryos were abdominally injected with 5-Bromo-2'-deoxy-uridine (BrdU) (20 mM) for BrdU labeling.
RNA synthesis and RNA microinjection
Capped RNAs were synthesized using the MESSAGE mMACHINE kit (Ambion). One animal dorsal blastomere was injected for phenotype observations at the 8-cell stage. The amount of injected synthetic RNAs were as follows; 75 pg of lacZ, 100 pg of EGFP, 225 pg of hmgb3, 250 pg of hmgb3 (mut), 100 pg of ubc9, 200-800 pg of ubc9 (C93A), 200 pg or 400 pg of sumo-Sp1-GR, 800 pg of Sp1(17-723)-GR, 400 pg of Sp1-GR.
X-gal staining and in situ hybridization
Embryos were grown to a desired stage and fixed in MEMFA (0.1 M MOPS (pH 7.4), 2 mM EGTA, 1 mM MgCl 2 , 3.7% formaldehyde) for 30 min and transferred into the X-gal staining solution until staining was apparent. In situ hybridization was performed essentially as described (Harland, 1991) . RNA probes of Xenopus hmgb3 and Xenopus rax were previously described (Terada et al., 2006) .
Quantification of enlarged eye size
Embryos injected with synthetic RNA were grown to stage 37/38 and fixed in MEMFA followed by X-gal staining. Quantification of enlarged eye was performed as previously described (Terada et al., 2006) . The eye diameters were measured by Image J and used to calculate the percent increase in eye diameter on the injected side to the un-injected side. The epidermis overlaying the eye was removed.
Animal cap dissections
Animal caps were dissected from stage 8/9 embryos in 0.5x MMR (Marc's Modified Ringer's solution). The caps were incubated until sibling embryos reached stage 19/20 and then subjected to further analysis.
Immunohistochemistry
Immunostaining of frozen sections was performed essentially as described previously with minor modifications (Terada et al., 2006) . A blocking solution containing 0.2% of TritonX-100 was used. Sections were incubated for 1 h in 2N HCl prior to BrdU immunodetection. For immunostaining, anti-β-galactosidase (β-gal) antibody (Promega, #Z3781), anti-phospho-histone H3 antibody (Upstate, #06-570), antiBrdU antibody (Fitzgerald, #20-BS17), anti-calbindin (calbiochem #PC253L), anti-islet1 (DSHB, clone 39.4D5), and anti-PCNA antibody (DAKO, M0879) were used for primary antibodies, Cy3-conjugatedanti-rabbit IgG (Jacson ImmunoResearch Laboratories, #711-165-152), Cy3-conjugated-anti-mouse IgG (Jacson ImmunoResearch Laboratories, #711-165-150), Alexa Fluor 488-conjugated-anti-sheep IgG (Invitrogen, #A11015) and Alexa Fluor 488-conjugated-antimouse IgG (Invitrogen, #A11001) were used for secondary antibodies. For immunoprecipitation and Western blots, anti-HA antibody (Santa Cruz, #sc-805), anti-myc antibody (Santa Cruz, #sc-40), anti-FLAG antibody (M2) (Sigma, #F3165) were used. 
In vivo lipofection
DNA was lipofected into the anterior neural fold of stage 18 embryos as previously described (Dorsky et al., 1997) . EGFP DNA was co-lipofected to mark the lipofected cells. Embryos were fixed at stage 41 and sectioned at a thickness of 10 μm. EGFP-positive cells were counted and the cell type was identified based upon their laminar position and morphology as previously described (Dorsky et al., 1997) .
Analysis of nuclear density, cell death, and BrdU-positive or phospho-histone H3 (pH3)-positive cells , lacZ/hmgb3, (n, r) = (34, 1.06), (36, 1.02), (32, 1.05) (E) and lacZ/ubc9 (93A), (n, r) = (36, 1), (31, 0.99), (33, 0.99) (F). Differences in eye diameter between the injected side and the uninjected side were classified as indicated in the right side of (F) and the ratio of each class to the total number are indicated (D-F). Differences in eye diameter between the injected side and the uninjected side were classified as indicated at the right side and the ratio of each class to the total number is indicated (L). Green arrows indicate reduced eye size (C', J'). Yellow arrow indicates the enlarged eye (E').
DAPI-positive cells in an arbitrary unit area (in the inner nuclear layer) were counted and cell density was calculated. TUNEL assay was performed according to the instruction manual protocol. The number of apoptotic cells and DAPI-positive signals were counted, and percentages of apoptotic cells were calculated. The number of BrdUpositive cells and DAPI-positive signals were counted, and percentages of BrdU-positive cells were calculated (stage 32/33) or BrdUpositive cells were counted (stages 40 and 41). To examine the ratio of the number of pH3-positive cells to the total number of cells, the number of pH3-positive cells and DAPI-positive signals were counted, and percentages of pH3-positive cells were calculated. To examine the ratio of the number of BrdU-labeled cells to the total number of cells, three adjacent serial sections corresponding to the central retina were prepared. One of the these sections was stained with an anti-BrdU antibody, one was stained with DAPI, and the third was stained with an anti-β-gal antibody, since HCl treatment makes DAPI staining of nucleus and anti-β-gal staining inefficient. The serial sections in which almost all retinal cells were stained with an anti-β-gal antibody were used for subsequent analysis. Each analysis was conducted on three to nine eyes for each experiment, and for each eye the average value was calculated from two to three sections.
Analysis of cell differentiation by immunohistochemistry of BrdU-incorporating cells in the developing retina
Embryos injected with lacZ or lacZ/ubc9/hmgb3 RNAs at the eight cell stage were injected with BrdU at stage 40/41. Injected embryos were raised to stage 46 and harvested. Retinal sections were co-immunostained with an anti-BrdU antibody and antibodies to retinal neuron markers. Image acquisition and analysis of the signals obtained were performed using Zeiss Confocal LSM510 Microscope.
Immunoprecipitation assay, sumoylation assay and Western blots 293T cell lysates or Xenopus embryo lysates, which were injected with synthetic RNAs, were prepared in immunoprecipitation (IP) buffer (50 mM Tris•HCl, pH 7.5, 1 mM EDTA, 2 mM MgCl 2 , 150 mM NaCl, 1 mM Phenylmethylsulfonyl fluoride, 0.5% TritonX-100) in the presence of protease inhibitor tablets (Roche) and spun at 17,400g for 10 min at 4°C. N-ethylmaleimide was added (20 mM) to IP buffer when sumoylation of proteins were detected. The indicated antibodies and Protein G sepharose (Amersham) were added to the supernatants, and incubated at 4°C overnight. The sepharose beads were washed five times with IP buffer. Western blots were performed with indicated antibodies.
Real-time PCR
Total RNA was reverse-transcribed by Superscript II (Invitrogen) using random primers. Real-time PCR was performed using the Thermal Cycler Dice Real Time System (TAKARA) and SYBR GreenER qPCR SuperMix Universal (Invitrogen), according to the manufacturer's protocols. Quantified RNA values were normalized with those of ribosomal RNA. Quantitative analysis was performed at least three times and shown with standard errors.
Plasmids and PCR primers
Details of plasmid construction and the primer sequences used for plasmid construction are available upon request.
Results
Ubc9 is expressed in the developing CNS in Xenopus embryos
We previously found that hmgb3 is essential for proliferation of retinal progenitors (Terada et al., 2006) . In the current study we performed a yeast two-hybrid screen to identify a factor(s) that interacts with hmgb3 protein in the context of retinal development. A full-length hmgb3 coding sequence, fused in-frame to the yeast Gal4 DNA binding domain was expressed in the AH109 strain and this yeast strain was used to screen a mouse retinal cDNA library fused with the Gal4 activation domain. In this screen we identified ubc9 as an interacting protein with hmgb3 (Fig. 1A, B) . To confirm the specificity of hmgb3-ubc9 association, as well as to identify the region(s) of hmgb3 responsible for the interaction, we constructed a series of hmgb3 deletion mutants in the pGBKT7 vector (Fig. 1A ) and expressed each of these in AH109 yeast transformed with pGADT7-ubc9. The ability to grow on medium lacking adenine and histidine revealed that hmgb3 has a ubc9-interacting domain in the N-terminal region (1-91 amino acids). We named this mutant hmgb3_1 (Fig. 1A) . To identify the region of ubc9 responsible for its interaction with the hmgb3 protein, we pursued a deletion-based interaction assay (Fig. 1B) . We observed that ubc9(93A), which is a inactive form of ubc9, can bind to hmgb3, suggesting that enzymatic activity is not required for ubc9 to bind to hmgb3 (Fig. 1B) . All partial fragments of ubc9 failed to interact with hmgb3, suggesting that a full-length ubc9 is required for interaction with hmgb3. We also detected ubc9 and hmgb3 interaction by co-immunoprecipitation assay using 293T cells transfected with ubc9 and hmgb3 expression constructs (Supplementary Fig. S1 ). We then analyzed the expression pattern of ubc9 in developing Xenopus embryos, and found that ubc9 is expressed mainly in the developing central nervous system (CNS) including the developing retina ( Fig. 1C -E, I, J). In the developing retina, ubc9 appeared to be expressed in retinal progenitors (Fig. 1I , J) and restricted to the CMZ, where retinal stem cells reside, as development proceeded (Fig. 1K) . Thus, the expression pattern of ubc9 was similar to that of hmgb3 in Xenopus embryonic development (Fig. 1C-N ) (Terada et al., 2006) .
Ubc9 and hmgb3 are functionally associated in retinal development
We focused our analysis on the retina in the current study, although ubc9 is expressed ubiquitously in the developing Xenopus CNS. Ubc9 has been reported to be expressed in the progenitor/stem cells in the developing rat CNS as well (Watanabe et al., 2008) , however, the roles of ubc9 in progenitor/stem cells in the rat CNS are unknown. Thus, we investigated a possible role of ubc9 in retinal progenitor/stem cells by taking advantage of the Xenopus system so that we can perform overexpression and/or loss-of-function experiments on several genes simultaneously in order to evaluate functional interactions between genes of interest.
We first tested whether or not ubc9 sumoylation activity is required for hmgb3 to induce eye enlargement using a sumoylation activity- Fig. 3 . Ubc9 and hmgb3 function synergistically in a hmgb3 sumoylation-independent manner. (A-E) Overexpression of lacZ alone (A, C-E), lacZ/ubc9/hmgb3 (B, C), lacZ/hmgb3 (D) or lacZ/ubc9 (E) in Xenopus embryos. Embryos were harvested at stage 37/38 (A-E) and injected side is indicated by β-gal activity in blue (A, B). Yellow arrow indicates the enlarged eye (B). Diameters of the eyes were compared between the injected side and the uninjected side (C-E). Differences in eye diameter between the injected side and the uninjected side were classified as indicated in the right side of Fig. 2F , and the ratio of each class to the total number are indicated (C-E). Data are means from three experiments with the numbers indicated as follows ± s.e.m. (C-E). The numbers of embryos analyzed (n) and the mean of the ratio of eye size between injected side and uninjected side (r): lacZ, (n, r) = (32, 0.96), (31, 0.99), (38, 0.99) (C-E), lacZ, ubc9 plus hmgb3, (n, r) = (32, 1.12), (36, 1.09), (41, 1.07) (C), lacZ/hmgb3, (n, r) = (31, 1.04), (31, 0.99), (38, 1.06) (D), lacZ/ubc9, (n, r) = (20, 1), (26, 0.98), (45, 1) (E). (F) The structure of hmgb3 and hmgb3 (mut). Lysine residues with a high probability of sumoylation are represented. Four lysine residues were substituted with arginine residues (hmgb3 (mut)). (G-I) Overexpression of lacZ alone (G-I), lacZ/ubc9/hmgb3 (mut) (G), lacZ/hmgb3 (mut) (H) or lacZ/ubc9 (I) in Xenopus embryos. Embryos were harvested at stage 37/38 (G-I). The effects of genes of interest were analyzed as in C-E (G-I). Data are means from three experiments with the numbers indicated as follows ± s.e.m. (G-I). The numbers of embryos analyzed (n) and the mean of the ratio of eye size between injected side and uninjected side (r): lacZ, (n, r) = (35, 0.98), (35, 0.99), (33, 1) (G-I), lacZ/ubc9/hmgb3 (mut), (n, r) = (37, 1.09), (32, 1.06), (30, 1.07) (G), lacZ/hmgb3 (mut), (n, r) = (36, 1.05), (34, 1.02), (32, 1) (H), and lacZ/ubc9, (n, r) = (35, 1), (33, 0.99), (31, 1) (I). (J) Embryos were injected with synthetic RNAs of indicated and harvested at stage 28 followed by an immunoprecipitation (IP) assay using an anti-FLAG antibody, SDS-PAGE and Western blot analysis using an anti-FLAG antibody. Lysates of embryos were aliquoted before IP and used for SDS-PAGE, Western blotting, and probed with an anti-HA peptide antibody as a loading control. Asterisks indicate sumoylated bands. Arrows indicate the heavy chain and light chain of mouse IgG. deficient mutant of ubc9, ubc9 (C93A) (Nowak and Hammerschmidt, 2006) . As we previously reported, upon hmgb3 overexpression, the number of embryos which exhibited enlarged eye size compared to that of lacZ-injected embryos modestly increased (Figs. 2A, A', E, E' and 3D) (Terada et al., 2006) . While strong inhibition of ubc9 by 800 pg of ubc9(93A) injection resulted in small eyes ( Supplementary Fig. S2A , B), weak inhibition of ubc9 function by injection of a small amount of ubc9 (93A) RNA (200-500 pg) did not cause a significant effect on eye development (Fig. 2B , B', F, H, H', L). Therefore, we injected 200 pg of ubc9(93A) and hmgb3 to examine the functional interaction between ubc9(93A) and hmgb3. We observed that it was sufficient for the suppression of hmgb3-induced eye enlargement (Fig. 2C, C', D) . More than merely suppressing eye enlargement, co-injection of ubc9(93A) and hmgb3 caused a reduction of eye size, suggesting that hmgb3 augmented the negative effect of ubc9(93A). We then performed partial inhibition experiments of ubc9 and hmgb3 alone, or both proteins together. We previously reported that 1 pmol of hmgb3 morpholino oligo (MO) injection results in a small eye phenotype (Terada et al., 2006) . Hmgb3 MO affects eye growth in a dose dependent manner ( Supplementary Fig. S3A-C) . We induced a partial inhibition of hmgb3 by injecting 0.2 pmol of hmgb3 MO (Fig. 2G, G' , J, J', K, K'). The inhibition of each protein alone did not show a significant effect (Fig. 2G, G' , H, H', L), and ubc9 (93A) and control MO did not affect eye growth (Fig. 2I, I') , however, the inhibition of both ubc9 and hmgb3 resulted in reduced eye size (Fig. 2J, J', L) , indicating that the cooperative functioning of ubc9 and hmgb3 is essential for normal eye growth in Xenopus. This effect was rescued by the co-injection of ubc9 (Fig. 2K, K', L) . We previously demonstrated that the effect of the hmgb3 MO was rescued by hmgb3 RNA injection (Terada et al., 2006) . These observations indicate that effects of hmgb3 MO and ubc9 (93A) were specific to each target. These results suggest that ubc9 and hmgb3 are functionally associated in a sumoylation activity-dependent manner to regulate eye growth.
Consensus sumoylation lysine residues are not required for functional association between ubc9 and hmgb3
We next performed ubc9 and hmgb3 overexpession experiments. Overexpression of both ubc9 and hmgb3 resulted in a high frequency of enlarged eye size (Fig. 3A-C) , while overexpression of hmgb3 or ubc9 alone produced a weak effect on eye size (Fig. 3D, E, I ). In addition, ubc9/hmgb3 overexpression increased the mean eye size compared with the mean eye size of the eyes overexpressing hmgb3 alone ( Supplementary Fig. S4A ). Functional cooperation between ubc9 and hmgb3 suggests that the hmgb3 protein is modified by sumoylation, leading to enhancement of progenitor proliferation. Alternatively, ubc9 may regulate eye growth by sumoylation of other target protein(s). In order to test this possibility we first examined , n = 3 eyes, 5 sections (hmgb3/ ubc9), (G) n = 3 eyes, 9 sections (lacZ), n = 3 eyes, 9 sections (lacZ/hmgb3/ubc9), (L) n = 6 eyes, 18 sections (lacZ), n = 4 eyes, 12 sections (hmgb3/ubc9) (**P = 0.0022, Student's ttest), (M) n = 9 eyes, 29 sections (lacZ), n = 5 eyes, 13 sections (hmgb3/ubc9 (93A)). (N-P) Embryos were lipofected with expression construct into anterior neural region. Retinal sections were prepared at stage 41 and the numbers of EGFP-positive cells in cell clusters, which appear to be derived from a single retinal progenitor cell respectively, were counted. EGFP-introduced (N) and EGFP/ubc9/hmgb3-introduced retina (O). The average of the number of cells in each cell cluster (clone size) was calculated (EGFP: 22 retina, 478 cells; EGFP/ubc9/hmgb3: 22 retina, 499 cells) (*P = 0.047, Student's t-test) (P). Data are means ± s.e.m. re: retina ; le: lens; rpe: retinal pigment epithelium. whether or not hmgb3 is modified by sumoylation. Hmgb3 has three lysine residues that are positioned in the consensus motif of sumoylation and one lysine residue with a high probability of sumoylation (http://www.abgent.com/doc/sumoplot; Fig. 3F ). We transfected 293T cells with ubc9, hmgb3 and sumo-1 expression vectors. We did not detect significant sumoylation of hmgb3 (data not shown). We next substituted the four lysine residues of hmgb3 with arginine resides by mutagenesis to make hmgb3 (mut) (Fig. 3F ). This substitution resulted in little effect on the cooperative function between ubc9 and hmgb3 for eye growth ( Fig. 3C, G ; Supplementary  Fig. S4B ). The effect of hmgb3 (mut) on eye enlargement was also similar to that of hmgb3 ( Fig. 3H; Supplementary Fig. S4B ), suggesting that hmgb3 is not a sumoylation target of ubc9. In order to examine if ubc9 sumoylates proteins other than hmgb3, we overexpressed ubc9, ubc9(93A), FLAG-tagged sumo-1 or HA-tagged hmgb3 in Xenopus embryos, followed by SDS-PAGE and Western blots. We observed an enhanced sumoylation by ubc9 overexpression (Fig. 3J) . These results showed that ubc9 and hmgb3 act in an hmgb3 sumoylationindependent manner, implying that ubc9 exerts sumo-modifying actions on protein(s) other than hmgb3 to regulate eye growth.
Overexpression of ubc9 and hmgb3 suppresses cell cycle exit of retinal progenitor cells
Overexpression of both ubc9(93A) and hmgb3 resulted in reduced eye size (Fig. 2C, C', D) . We, therefore, examined whether cell cycle arrest and/or apoptosis are induced in retinal progenitors as previously reported (Nowak and Hammerschmidt, 2006) . In the retina overexpressing ubc9(93A) and hmgb3 we observed that the ratio of the number of phospho-histone H3 (pH3)-positive cells to the number of total cells in the retina increased compared to that in the lacZ-injected retina (Fig. 4A-B'', D) , while 200 pg of ubc9(93A) alone showed little effect ( Fig. 4C-C'', D) , suggesting that cell cycle arrest is induced by both ubc9(93A) and hmgb3. We also observed an increase in the number of apoptotic cells in the retina overexpressing ubc9(93A) and hmgb3 (Fig. 4E) .
On the other hand, we observed that overexpression of ubc9 and hmgb3 resulted in an enlarged eye (Fig. 3A-C) . The enlarged eye phenotype observed upon overexpression of both ubc9 and hmgb3 might be due to their effects on the formation of the eye field, cell death, cell density, and/or cell proliferation. In order to investigate this point, we examined the eye field at stage 15/16 in ubc9 & hmgb3-injected embryos, and we observed some embryos showed a subtle expansion of the eye field, while ubc9(93A) and hmgb3 have little effect (ubc9/ hmgb3, rax↑, in 5 of 14 embryos, Supplementary Fig. S5A-C) . Therefore, we also examined other eye field genes, including pax6, optx2 and vsx1 ( Supplementary Fig. S6 ). We did not observe a significant effect on those genes ( Supplementary Fig. S6A-I ). These observations suggest that ubc9 and hmgb3 overexpression does not have a significant effect on eye field formation ( Supplementary Figs. S5 and S6) . We then examined cell density in the retina by analyzing nuclear density, and did not observe a significant difference between injected eyes and uninjected eyes (Fig. 5A-C) . We then examined cell death by TUNEL assay. We failed to observe a significant difference between the ubc9/hmgb3-overexpressed retina and the control retina (Fig. 5D) . We next analyzed cell proliferation by labeling proliferating progenitor cells using BrdU. We injected Xenopus embryos with BrdU at stage 32/33 when almost all cells in the retina are mitotic retinal progenitors (Fig. 5E-G) (Holt et al., 1988) . The ratio of the number of BrdU-positive cells to the number of total cells was not significantly different between the ubc9/hmgb3-overexpressed retina (Fig. 5F-F'' , G) and the control retina ( Fig. 5E-E'' , G). In addition, the ratio of the number of pH3-positive cells to the number of total cells ( Supplementary Fig. S9A-C) and the ratio of the number of pH3-positive cells to the number of proliferating cell nuclear antigen (PCNA)-positive cells (proliferating cells) (Supplementary Fig. S9D-H) were not significantly different between the ubc9/ hmgb3-overexpressing retina and the control retina ( Supplementary  Fig. S9A-H) . These results suggest that the cell cycle itself was not largely affected. We next labeled Xenopus embryos with BrdU at stage 41 when retinal development is almost completed and, therefore, proliferating progenitor/stem cells are observed only in the CMZ at this stage. We observed few proliferating cells outside the CMZ in the control retina (Fig. 5H) . In contrast, we observed a significantly increased number of proliferating cells outside the CMZ in the ubc9/hmgb3-injected retina (Fig. 5I , J, J', L), suggesting that cell cycle exit of retinal progenitors is suppressed. We did not observe an increase of BrdUpositive cells in the hmgb3/ubc9 (93A)-injected retina (Fig. 5K, M) . We next examined whether ubc9 and hmgb3 act cell-autonomously. We lipofected EGFP alone or EGFP/ubc9/hmgb3 into retinal progenitors and observed an increase in the clone size in the EGFP/ubc9/hmgb3-overexpressing retina compared to that observed in the EGFP-overexpressing retina ( Fig. 5N-P) , indicating that ubc9 and hmgb3 inhibit the cell cycle exit of retinal progenitors in a cell-autonomous manner.
We also examined the timing of when the enlarged eye phenotype manifests. We observed an enlarged eye phenotype at around stage 35/36 by visual inspection. Before stage 35/36, it is difficult to measure the eye sizes of embryos, therefore we examined the timing of the larger eye phenotype manifestation itself by whole mount in situ hybridization using eye marker genes, including rax/Rx, pax6 and six3 at earlier stages than stage 35/36. We observed that an enlargement of the eye region began after stage 28 ( Supplementary  Fig. S7A-O) . Since it is known that retinal neurons begin to be generated after stage 26 in Xenopus, our observation that eye regions represented by eye marker gene expression expanded after stage 28 would be consistent with the idea that ubc9/hmgb3 affect cell cycle exit, leading to an enlarged eye phenotype.
The effect of ubc9 and hmgb3 on cell fate in the developing retina
We observed proliferating cells in the ubc9/hmgb3-overexpressing retina at stages 40/41 (Fig. 5I , J, L), and then examined whether the proliferating cells at stage 41 can differentiate into retinal neurons. We injected Xenopus embryos, which had been injected with lacZ alone or lacZ/ubc9/hmgb3, with BrdU at stage 41 to label proliferating cells and harvested the embryos at stage 46. We subsequently performed immunostaining of retinal sections with antibodies to BrdU and markers of retinal neurons, such as calbindin (Fig. 6A-H) or islet1 (Fig. 6I-L) . We observed co-staining of BrdU and retinal markers in the lacZ/ubc9/hmgb3-overexpressing retina (Fig. 6A-D' , K, L), but not in the lacZ-overexpressing retina (Fig. 6E-H, I , J), suggesting that ubc9/hmgb3-induced proliferating cells were retinal progenitor cells. We next examined whether ubc9/hmgb3 affects the cell fate decision in the developing Xenopus retina. We did not observe a significant effect on cell fate decision by ubc9 and hmgb3 overexpression in the developing Xenopus retina (Fig. 6M, N) .
Overexpression of ubc9 and hmgb3 suppresses the p27
Xic1 expression in the developing retina Several cell cycle regulators have been reported to play significant roles in retinal development (Donovan and Dyer, 2005; Levine and Green, 2004) . Among cell cycle regulators, CKI genes, including p27 Kip1 , p57 Kip2 , p19, gadd45γ and p27
Xic1
, have been demonstrated to play significant roles in eye growth in mice and Xenopus. Only p27 Xic1 , p19 and gadd45γ genes have been identified so far in Xenopus. We examined the effects of ubc9 and hmgb3 on the expression of CKI genes in the retina, where the injected side was identified by EGFP fluorescence (Fig. 7A-B' ). We found that while injection of EGFP did not affect on the expression of p27 Xic1 , a CKI gene (Fig. 7C, D) , p27
Xic1 expression was severely attenuated in the retina overexpressing both ubc9 and hmgb3 when examined by whole mount in situ hybridization ( Fig. 7E-H ↓, in 14 of 33 embryos). To confirm the attenuation of p27 Xic1 expression in the developing retina, we prepared retinal sections after whole mount in situ hybridization to detect p27 Xic1 expression. We observed that p27 Xic1 expression was attenuated in the developing retina overexpressing lacZ, ubc9 and hmgb3, while not in the retina overexpressing lacZ alone (Fig. 7K, L) . We next examined the timing of when the attenuation of p27 Xic1 expression appears upon ubc9 and hmgb3 overexpression. In the eye, the expression of p27 Xic1 can be detected as early as stage 26 (Ohnuma et al., 1999 ↓, in 17 of 77 embryos at stage 28). We did not observe a significant ubc9 and hmgb3 effect on the expression of cell cycle regulators including cyclin D1, cyclin A2, cyclin B1 and hairy2 by RT-PCR (data not shown). We also did not observe a significant difference of CKI gene gadd45γ expression (Fig. 7I , J, EGFP/ubc9/hmgb3, gadd45γ ↓, in 1 of 20 embryos) (Decembrini et al., 2006) , suggesting a selective gene regulation of CKI genes is mediated by ubc9 and hmgb3. We also examined the effect of ubc9 and hmgb3 on cell cycle inhibitor p21 expression by quantitative-PCR using total RNAs from animal caps injected with hmgb3 or ubc9/hmgb3 (Supplementary Fig. S8 ). The expression of p21 appeared to be affected by hmgb3 or ubc9/hmgb3, although the differences of expressions of p21 in the control were not statistically significant (Supplementary Fig. S8 ). These results suggest that hmgb3 and ubc9 affect p21 expression, leading to the inhibition of the cell cycle exit of retinal progenitors. On the other hand, we failed to detect a significant signal of p19 in the eye of Xenopus embryos by whole mount in situ hybridization (data not shown). These observations suggest that ubc9 and hmgb3 regulate cell cycle inhibitor expression.
Role of sumoylated Sp1 in retinal growth
Sumoylation of transcription factors typically induces their transcriptional repression (Gill, 2005) . We examined Sp1 as a candidate target of sumoylation, since it has been reported that Sp1 has potential sites to be sumoylated and is involved in cell cycle regulation (Black et al., 2001; Spengler and Brattain, 2006; Wang et al., 2008) . First, we found that Sp1 is predominantly expressed in the developing Xenopus CNS, including the eye (Fig. 8A-D) . Mammalian Sp1 can be sumoylated at the Lys 16 residue (Spengler and Brattain, 2006; Wang et al., 2008) , and Sp1 also has this sumoylatable Lys 16 residue matching the sumoylation consensus residues. Therefore, we next examined whether or not Xenopus homolog of Sp1 can be sumoylated using 293T cells. We introduced plasmid DNAs encoding proteins of interest into 293T cells followed by SDS-PAGE and Western blot analysis (Fig. 8E, F) . Sumo-modified proteins have a~20 kDa higher molecular weight compared with unmodified proteins. We performed Western blot analysis and observed a slower migrating Sp1 (1-723) isoform, whereas we did not observe a slower migrating isoform of Sp1 (17-723) lacking the 16N-terminal amino acids containing the potential sumoylation Lys 16 residue (Fig. 8E) . These results indicate that Xenopus Sp1 can be sumoylated (Fig. 8F ). Fusion of a sumo moiety to transcription factors mimics the effect of sumo that is covalently linked to proteins on a native lysine (Ross et al., 2002; Shalizi et al., 2006) . We fused sumo-1 (1-95), which lacks the last 6 amino acids including the sumo hydrolase cleavage site, to Sp1 (17-723), creating sumo-Sp1. In order to investigate a functional role of sumo-Sp1 in retinal progenitor/stem cells, we fused sumo-Sp1 to the hormone-binding domain of glucocorticoid receptor (GRHBD), creating sumo-Sp1-GR, whose activity can be regulated by dexamethasone (DEX) (Fig. 8G ). This system has been used to conditionally activate transcription factors during Xenopus embryogenesis (Suzuki and Hemmati-Brivanlou, 2000; Takebayashi-Suzuki et al., 2003) . We examined the effect of sumo-Sp1-GR injection on eye development after stage 25-28 with DEX treatment. We observed an eye enlargement in DEX-treated embryos on the injected side (Fig. 8I, J) , while not in DMSO-treated embryos (Fig. 8H, J) . We next investigated the expression of p27 Xic1 in the sumo-Sp1-GR-injected embryos. We observed an attenuation of p27 Xic1 expression in the retina of DEX-treated embryos in the injected side (Fig. 8L, N) (sumo-Sp1-GR, DEX, p27
Xic1 ↓, in 6 of 20 embryos), while not in DMSO-treated embryos (Fig. 8K, M) 
Xic1 ↓, in 0 of 12 embryos), indicating that sumo fusion of Sp1 can repress p27 Xic1 expression in the developing Xenopus retina. On the other hand, we observed a reduced eye phenotype in the embryos injected with un-sumoylable Sp1, Sp1(17-723)-GR, with DEX treatment, but not in those with DMSO treatment (Fig. 8O, P) . We also examined the effect of sumo-Sp1-GR on retinal progenitor proliferation. We injected sumo-fused Sp1-overexpressing embryos with BrdU at stage 41. We observed BrdU-positive cells in the retina of DEX-treated embryos, but not in DMSO-treated embryos, outside the CMZ (Fig. 8Q-S) , similar to the proliferating cells we observed in the retina of ubc9/hmgb3-injected embryos (Fig. 5I , J, L). These results suggest that sumo modification regulates the cell cycle exit of proliferating retinal progenitor cells in the developing Xenopus.
Roles of ubc9/hmgb3 and Sp1 in retinal growth
We performed hmgb3 MO/ubc9(93A) or hmgb3 MO/ubc9(93A)/ sumo-Sp1-GR injection into embryos. We observed an almost normal eye size in embryos injected with hmgb3 MO/ubc9(93A)/sumo-Sp1- GR (Fig. 9A) , while we observed a reduced eye phenotype in embryos injected with hmgb3MO/ubc9(93A) (Fig. 9A) . We next performed lacZ alone or lacZ/ubc9/hmgb3/Sp1(17-723)-GR injection into embryos.
We observed an almost normal eye size in embryos injected with lacZ alone (Fig. 9B) . On the other hand, we observed an enlarged eye phenotype in embryos injected with lacZ/ubc9/hmgb3/Sp1(17-723)- GR when the embryos were treated with DMSO (Fig. 9B ). In contrast, we observed a reduced eye phenotype in embryos injected with lacZ/ ubc9/hmgb3/Sp1(17-723)-GR when the embryos were treated with DEX (Fig. 9B) . These results suggest that Sp1 acts downstream of ubc9/hmgb3 in Xenopus eye development.
Discussion
In this study we demonstrated that protein sumoylation activity has a significant role in the regulation of cell cycle exit in the developing Xenopus retina. First, ubc9 is expressed in retinal progenitors in the developing retina and subsequently its expression is confined to the CMZ, where retinal stem cells reside. Second, coinjection of ubc9 and hmgb3 produced ectopic BrdU-positive dividing cells in the retina at stage 41 in a sumoylation activity-dependent manner, while BrdU-positive cells were not detected in the control retina except in the CMZ. Third, the expression of a CKI gene, p27
Xic1
, was attenuated upon overexpression of ubc9 and hmgb3. Fourth, we found that the Xenopus homolog of mammalian Sp1 can be modified by sumoylation, and sumo-fused Sp1 has a potential to negatively regulate p27
Xic1 expression.
Role of sumo modification in retinal development
Post-translational protein modifications, including phosphorylation, acetylation and ubiquitinylation have been known to act like a switch to activate or inactivate a protein or a protein complex in a cellular context-dependent manner. Recently, emerging evidence indicates that protein sumoylation modulates protein function, including the regulation of transcription factors and the subcellular localization of proteins, to control a wide variety of cellular events (Geiss-Friedlander and Melchior, 2007; Hay, 2005; Johnson, 2004) . We found that ubc9 is expressed in retinal progenitor cells. In our experiment, a prolonged expression of ubc9 and hmgb3 suppressed cell cycle exit, resulting in retinal progenitor proliferation outside the CMZ at stages 40/41 when progenitor proliferation is not normally observed. This observation suggests that protein sumoylation plays an essential role as a functional switch to control the cell cycle exit in retinal development.
The molecular events that determine the timing of "ON" and "OFF" sumo modification by affecting ubc9 expression in the retinal progenitors have been unknown. Ubc9 expression may decrease with different speeds among progenitors. Alternatively, there may be mechanisms that allow selected cells to receive extrinsic signals, leading to the regulation of sumo modification in the cells that received the signal. However, further investigation will be required to examine these possibilities.
Role of Ubc9 in cell cycle regulation
It has been demonstrated that functions of CENP-E and TopII are controlled by sumoylation, leading to the proper regulation of chromosome segregation and subcellular localization of proteins during the G2/M phase of the cell cycle in animal cells (Dawlaty et al., 2008; Zhang et al., 2008) . In zebrafish, ubc9 is required for G2/M progression of progenitor cells in the developing retina at late developmental stages (Nowak and Hammerschmidt, 2006) . However, the role of ubc9 other than cell cycle regulation of the G2/M phase has been poorly understood. It may be that cell cycle arrest at the G2/M phase in an ubc9 loss-of-function experiment makes it difficult to analyze the function of sumoylation during other phases in the cell cycle. Indeed, we also observed that ubc9(93A)/hmgb3 overexpression appeared to confer a negative effect on eye growth.
An analysis of ubc9 functions in the cell cycle by overexpression experiments has not been reported as far as we know. We found that overexpression of ubc9 and hmgb3 affected BrdU uptake in retinal progenitors at stages 40/41 and also found that overexpression of ubc9 and hmgb3 in retinal progenitors resulted in an increase in the clone size. Considering these findings, ubc9 may have a significant role in the control of cell cycle withdrawal in retinal progenitors.
In the hematopoietic system, hmgb3 regulates the balance between hematopoietic stem cell (HSC) self-renewal and differentiation (Nemeth et al., 2006) . Hmgb3 is required for the transition of HSCs to progenitor cells, including common lymphoid progenitors and common myeloid progenitors. We observed that hmgb3 overexpression can induce c-myc expression in Xenopus explant cultures (Terada et al., 2006) . We examined whether ubc9 can enhance c-myc expression induced by hmgb3, but we observed little effect by ubc9 on c-myc expression, suggesting that ubc9 regulates progenitor proliferation by a mechanism other than the regulation of c-myc expression (data not shown). Although we suggested that ubc9 and hmgb3 inhibit the cell cycle exit of retinal progenitor cells, it remains to be addressed whether proliferating cells at later stages (stages 40/41) overexpressing ubc9/hmgb3 contain a population of cells possessing stem cell characteristics created by inhibiting the transition of retinal stem cells to retinal progenitors.
Role of Sp1 in retinal growth
Recently it was shown that Sp1 is sumoylated at N-terminus in mammalian cells, which negatively regulates Sp1 transcriptional activity (Spengler and Brattain, 2006) . Sumoylation of Sp1 was also reported to induce translocation of Sp1 to the cytosol and to induce proteolysis of Sp1 (Wang et al., 2008) . Sp1 is known to be involved in the expression of cell cycle inhibitors, including p27 Kip1 and p21
Cip1
. A study using siRNA against p27
Kip1 has demonstrated that Sp1 is required to increase the expression of p27 Kip1 through protein G kinase signaling (Cen et al., 2008) . The attenuation of p27 Xic1 expression by hmgb3 and ubc9 overexpression in the present study may be mediated by Sp1 degradation, leading to a low level of p27 Xic1 expression, although it was not completely clear whether or not this attenuation is mediated by active repression by sumo-modified Sp1. It is known that Sp3 also recognizes the same GC-rich sequence to which Sp1 binds and that Sp3 is modified by sumoylation resulting in repression of transactivator activity (Ross et al., 2002) . Our observation that the effect caused by hmgb3 and ubc9 is stronger than the effect caused by sumo fusion Sp1 mutants may suggest the existence of another target of ubc9 sumoylation in retinal development.
Interaction between hmgb3 and ubc9
Hmgb3 and ubc9(93A) overexpression caused a reduced eye phenotype, while hmgb3 and ubc9 overexpression resulted in an enlarged eye phenotype. In contrast, overexpression with 100 pg of ubc9 or 200 pg of ubc9(93A) alone showed little effect on Xenopus eye development. Our results strongly suggest that hmgb3 augmented both the negative effect of ubc9(93A) and positive effect of ubc9 on eye growth. We also observed cell cycle arrest at the G2/M phase and apoptosis in the ubc9(93A)/hmgb3-overexpressing retina, but not in the retina injected with 200 pg of ubc9(93A) only. This may be due to the augmentation of ubc9(93A) function by hmgb3, as the loss-offunction of ubc9 induces cell cycle arrest and apoptosis in the developing retina (Nowak and Hammerschmidt, 2006) . These results may reflect the functional interaction between hmgb3 and ubc9.
There have been studies demonstrating that a sumo E3 ligase induces cellular responses, including cell senescence, apoptosis and cell morphogenesis with ubc9 (Bischof et al., 2006; Shalizi et al., 2007) . These observations raise the possibility that ubc9 may require a co-factor(s) including E3 ligase to induce these various cellular responses. Therefore, we tested the possibility that hmgb3 acts as a sumo E3 ligase. We transfected 293T cells with HA-Sp1, sumo-1, ubc9 and/or hmgb3 expression constructs. As far as we examined, we failed to obtain evidence that hmgb3 acts as a sumo E3 ligase (data not shown). Although hmgb3 does not function as an E3 ligase, we still hypothesize that hmgb3 may function as a co-factor of ubc9 to regulate retinal progenitor proliferation. In addition, our current study implies that hmgb3 and ubc9 have functional associations regulating the proliferation of progenitor/stem cells in various tissues as well. Future studies are needed for further elucidation of these hypotheses.
